Markets stall under threat of government shutdown >>> READ MORE

XLV

This Big Biotech ETF Faces a Key Technical Test

Those who follow our blog know we are proponents of technical analysis in reading the trends of the market. A trend in this biotech ETF suggests opportunity More 

ABIOMED, Inc. (ABMD) a Great Buy in a Growing Industry

Medical device maker ABIOMED continues to grow top and bottom line results, and is a strong buy in an industry on the rise More 

Why Johnson & Johnson Is a Top Dow Pick (JNJ)

A study of analyst recommendations shows that Johnson & Johnson is the #17 broker pick, on average, out of the 30 stocks making up the Dow More 

4 Healthcare Stocks on Shaky Ground – MRK LLY AZN BMY

Biotechnology stocks have broken down, and certain pharmaceutical stocks are now following suit. Could Merck and other pharmas suffer more downside? More 

5 Misunderstandings About The Current Investing Environment

Many analysts believed the end of QE and the Fed rate hike wouldn't effect risk assets. Here is why they continue to be wrong... More 

Damage Control: Is It Too Late Too Become More Defensive?

A manufacturing recession doesn't matter until it does. Here is how anemic production looks today, and how to invest in this market... More 

Why The S&P 500’s Record High Seems So Far Away

Some bear markets feature dreadful price catastrophes that occur quickly. Was last May's S&P 500 high point the starting point for the next collapse? More